EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, IRWD: Ironwood Pharmaceuti

10 Jul 26 13:24
LAST:

4.470

CHANGE:
 0.20		OPEN:
4.730		HIGH:
4.730		ASK:
11.150		VOLUME:
1.32M
CHG(%):
4.28		PREV:
4.670		LOW:
4.370		BID:
271.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
10 Jul 264.7304.7304.3704.4701.32M
09 Jul 264.6904.7804.5504.6702.7M
08 Jul 264.8504.9284.5904.7704.0M
07 Jul 264.4804.6704.4104.4703.48M
06 Jul 264.3304.4704.2704.3803.0M
02 Jul 264.1704.3904.1604.3302.65M
01 Jul 264.1304.2904.0604.1201.65M
30 Jun 264.2504.3204.1204.2102.59M
29 Jun 264.0804.3553.9904.3003.5M
26 Jun 263.7904.1703.7904.1307.11M

PROFILE

Name:Ironwood Pharmaceuti
About:Ironwood Pharmaceuticals, Inc., a biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally. It markets linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation, as well as for pediatric patients suffering from functional constipation under the LINZESS and CONSTELLA names. The company is also developing IW-3300, a GC-C agonist for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis; and Apraglutide, a long-acting synthetic peptide analog of glucagon-like peptide-2 for short bowel syndrome patients dependent on parenteral support, as well as for acute graft versus host disease. It has strategic partnerships with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts.
Sector:Healthcare
Address:100 Summer Street, Boston, MA, United States, 02110
Website:https://ironwoodpharma.com
CUSIP:46333X108
CIK:0001446847
ISIN:US46333X1081
FIGI:BBG000GBZ3J2
LEI:549300PC8MR6QHH6P296

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:7.06 
Forward P/E:3.04 
PEG Ratio:-0.06 
Price to Sales:1.01 
Price to Book:-3.32 
Profit Margin:-0.03 
Operating Margin:0.53 
Return on Assets:0.16 
Return on Equity:0.00 
EPS Ratio:0.62 
Revenue:308.52M 
EBITDA:102.84M 
Shares:164.61M 
Market Cap:735.82M 

TECHNICAL INDICATORS

MA5:4.551.8%
MA10:4.391.9%
MA20:4.0510.4%
MA50:3.9114.3%
MA100:3.8117.4%
MA200:3.4728.7%
STO9:43.34
STO14:58.69
RSI14:72.91 
WPR14:-31.58
MTM14:0.65
ROC14:0.17 
ATR:0.28 
Week High:4.9310.2%
Week Low:4.274.7%
Month High:4.9310.2%
Month Low:3.2028.7%
Year High:5.7829.3%
Year Low:0.67567.1%

RECENT SPLITS

Date Ratio
02 Apr 20191194-1000